Natriuretic pro-peptides in idiopathic intracranial hypertension

Regulatory Peptides

Volumn 164, Issue 2-3, 2010, Pages 71-77

  Skau, Maren ^a   Goetze, Jens P ^b   Rehfeld, Jens F ^b   Jensen, Rigmor ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Endothelial dysfunction; Intracranial hypertension; Natriuretic peptides

Indexed keywords

ACETAZOLAMIDE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; FUROSEMIDE; NATRIURETIC PEPTIDE TYPE C; POTASSIUM; PROTEIN PRECURSOR; TOPIRAMATE;

ADULT; AGED; ARTICLE; BLOOD VESSEL TONE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INTRACRANIAL HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; VASCULAR ENDOTHELIUM;

ADULT; ATRIAL NATRIURETIC FACTOR; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; NATRIURETIC PEPTIDES; PSEUDOTUMOR CEREBRI; YOUNG ADULT;

EID: 77955844905     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.05.009     Document Type: Article

References (42)

1. Headache Classification Subcommittee of the International Headache Society The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(suppl 1):9-160.
2. Friedman D.I., Jacobson D.M. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002, 59:1492-1495.
3. Sugerman H.J., Felton W.L., Sismanis A., Kellum J.M., DeMaria E.J., Sugerman E.L. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999, 229:634-642.
4. Wong R., Madill S.A., Pandey P., Riordan-Eva P. Idiopathic intracranial hypertension: the association between weight-loss and the requirement for systemic treatment. BMC Ophthalmol 2007, 7:15. 10.1186/1471-2415-7-15.
5. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006, 27:47-72.
6. Scotland R.S., Ahluwalia A., Hobbs A.J. C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther 2005, 105:85-93.
7. Das S.R., Drazner M.H., Dries D.L., Vega G.L., Stanek H.G., Abdullah S.M., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005, 112:2163-2168.
8. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Wilson P.W., et al. Impact of obesity on plasma levels. Circulation 2004, 109:594-600.
9. van Kimmenade R., van Dielen F., Bakker J., Nijhuis J., Crijns H., Buurman W., et al. Is brain natriuretic peptide production decreased in obese subjects?. Am J Coll Cardiol 2006, 47:886-887.
10. Kaneko T., Shirakami G., Nakao K., Nagata I., Nakagawa O., Hama N., et al. C-type natriuretic peptide is the major natriuretic peptide in human cerebrospinal fluid. Brain Res 1993, 612:104-109.
11. Imura H., Nakao K., Itoh H. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol 1992, 13:217-249.
12. Dóczi T., Joó F., Vecsernyés M., Bodosi M. Increased concentration of atrial natriuretic factor in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage and raised intracranial pressure. Neurosurgery 1988, 23:16-19.
13. Kirchhoff C., Stegmaier J., Bogner V., Buhmann S., Mussack T., Kreimeier U., et al. Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J Neurotrauma 2006, 23:943-949.
14. Rosenfeld J.V., Barnett G.H., Sila C.A., Little J.R., Bravo E.L., Beck G.J. The effect of subarachnoid hemorrhage on blood and CSF atrial natriuretic factor. J Neurosurg 1989, 71:32-37.
15. Yamasaki H., Sugino M., Ohsawa N. Possible regulation of intracranial pressure by human atrial natriuretic peptide in cerebrospinal fluid. Eur Neurol 1997, 38:88-93.
16. Akdemir G., Luer M.S., Dujovny M., Misra M. Intraventricular atrial natriuretic peptide for acute intracranial hypertension. Neurol Res 1997, 19:515-520.
17. Steardo L., Nathanson J.A. Brain barrier tissues: end organs for atriopeptins. Science 1987, 235:470-473.
18. Johanson C.E., Duncan J.A., Klinge P.M., Brinker T., Stopa E.G., Silverberg G.D. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 2008, 5:10. 10.1186/1743-8454-5-10.
19. Rehfeld J.F., Goetze J.P. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 2003, 3:25-38.
20. Goetze J.P., Kastrup J., Pedersen F., Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002, 48:1035-1042.
21. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrinol Rev 2006, 27:47-72.
22. Espiner E.A., Leikis R., Ferch R.D., MacFarlane M.R., Bonkowski J.A., Frampton C.M., et al. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol 2002, 56:629-635.
23. Nielsen S.J., Rehfeld J.F., Goetze J.P. Mismeasure of C-type natriuretic peptide. Clin Chem 2008, 254:225-227.
24. Goetze J.P. Biosynthesis of cardiac natriuretic peptides. Results Probl Cell Differ 2010, 50:97-120.
25. Herman J.P., Dolgas C.M., Rucker D. Localization of natriuretic peptide activated guanulate cyclase mRNAs in the brain. J Comp Neurol 1996, 369:165-187.
26. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. N Engl J Med 1998, 339:321-328.
27. Charles C.J., Richards C.J., Espiner E.A. Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep. Endocrinol. 1992, 131:1721-1726.
28. Rose R.A., Giles W.R. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol 2008, 586:353-366.
29. Palmer S.C., Prickett C.R., Espiner E.A., Yandle T.G., Richards A.M. Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension 2009, 54:612-618.
30. Igaki T., Itoh H., Suga S., Hama N., Ogawa Y., Komatsu Y., et al. C-type natriuretic peptide in chronic renal failure and its action in humans. Kidney Int Suppl 1996, 55:S144-S147.
31. Bahrami S., Pelinka L., Khadem A., Maitzen S., Hawa G., van Griensven M., et al. Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Cri Care Med 2010, 38:161-166.
32. Dietmann A., Lackner P., Helbok R., Spora K., Issifou S., Lell B., et al. Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J 2008, 7:253. 10.1186/1475-2875-7-253.
33. Raichle M.E., Grubb R.L., Phelps M.E., Gado M.H., Caronna J.J. Cerebral hemodynamics and metabolism in pseudotumor cerebri. Ann Neurol 1978, 4:104-111.
34. Mathew N.T., Meyer J.S., Ott E.O. Increased cerebral blood volume in benign intracranial hypertension. Neurology 1975, 25:646-649.
35. Brooks D.J., Beaney R.P., Leenders K.L., Marshall J., Thomas D.J., Jones T. Regional cerebral oxygen utilization, blood flow, and blood volume in benign intracranial hypertension studied by positron emission tomography. Neurology 1985, 35:1030-1034.
36. Van Guilder G.P., Hoetzer G.L., Dengel D.R., Stauffer B.L., DeSouza C.A. Impaired endothelium-dependent vasodilation in normotensive and normoglycemic obese adult humans. J Cardiovasc Pharmacol 2006, 47:310-313.
37. Widlansky M.E., Gokce N., Keaney J.F., Vita J.A. The clinical implications of endothelium dysfunction. J Am Coll Cardiol 2003, 42:1149-1160.
38. Villela N.R., Kramer-Aguiar L.G., Bottino D.A., Wiernsperger N., Bouskela E. Metabolic disturbances linked to obesity: the role of impaired tissue perfusion. Arq Bras Endocrinol Metabol 2009, 53:238-245.
39. Hashimoto M., Akishita M., Eto M., Kozaki K., Ako J., Sugimoto N., et al. The impairment of flow-mediated vasodilation in obese men vith visceral fat accumulation. Int J Obes Relat Metab Disord 1998, 22:477-484.
40. De Jongh R.T., Ijzerman R.G., Serne E.H., Voordouw J.J., Yudkin J.S., de Waal H.A., et al. Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals. J Clin Endocrinol Metab 2006, 91:5100-5106.
41. Brook R.D., Bard R.L., Rubenfire M., Ridker P.M., Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001, 88:1264-1269.
42. Villela N.R., Aguiar L.G., Bahia L., Bottino D., Bouskela E. Does endothelial dysfunction correlate better with waist-to-hip ratio than with body mass index or waist circumference among obese patients?. Clinics 2006, 61:53-58.